Skip to content

Ocular Therapeutix OCUL Short- and long-term operating lease liabilities

Short- and long-term operating lease liabilities at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$125K-495%
Rumble, Inc. logo
Rumble, Inc.RUM
-$337.78K-40.4%
The Baldwin Insurance Group, Inc. logo
The Baldwin Insurance Group, Inc.BWIN
-$4.74M-16.2%
SolarEdge Technologies logo
SolarEdge TechnologiesSEDG
-$3.81M-13.9%
NextNav logo
NextNavNN
$77K-63.7%
Target Hospitality logo
Target HospitalityTH
-$2.3M-33.9%

Other financials

Income statement

See full
Revenue$10.8M+0.8%
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.16B+58.2%

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's short- and long-term operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's short- and long-term operating lease liabilities?
Ocular Therapeutix (OCUL) reported short- and long-term operating lease liabilities of $1.77M in Q1 2026.
How has Ocular Therapeutix's short- and long-term operating lease liabilities changed year-over-year?
Ocular Therapeutix's short- and long-term operating lease liabilities increased by 790.6% year-over-year, from -$256K to $1.77M.
What is the long-term trend for Ocular Therapeutix's short- and long-term operating lease liabilities?
Over 4 years (2021 to 2025), Ocular Therapeutix's short- and long-term operating lease liabilities has grown at a 5.1% compound annual growth rate (CAGR), from -$1.36M to -$1.66M.